Net profit of Jenburkt Pharmaceuticals rose 5.83% to Rs 10.16 crore in the quarter ended September 2025 as against Rs 9.60 crore during the previous quarter ended September 2024. Sales rose 10.53% to Rs 45.56 crore in the quarter ended September 2025 as against Rs 41.22 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales45.5641.22 11 OPM %28.7527.73 - PBDT15.0713.16 15 PBT14.3312.52 14 NP10.169.60 6 Powered by Capital Market - Live News

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 October 2025.Powered by Capital Market - Live News

Net profit of Jenburkt Pharmaceuticals rose 4.99% to Rs 7.79 crore in the quarter ended June 2025 as against Rs 7.42 crore during the previous quarter ended June 2024. Sales rose 9.19% to Rs 35.53 crore in the quarter ended June 2025 as against Rs 32.54 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales35.5332.54 9 OPM %25.1928.55 - PBDT10.9010.59 3 PBT10.1810.07 1 NP7.797.42 5 Powered by Capital Market - Live News

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News

Jenburkt Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be held on 18 August 2025.Powered by Capital Market - Live News